TerminatedPhase 2NCT02553330

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Incyte Corporation
Principal Investigator
Kathleen Butler, MD
Incyte Corporation
Intervention
Placebo Cream(drug)
Enrollment
90 enrolled
Eligibility
18-70 years · All sexes
Timeline
20152017

Study locations (18)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02553330 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials